Update in sepsis and pulmonary infections 2013

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 1, 2014, Pages 25-31

  Wunderink, Richard G ^a   Walley, Keith R ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Biomarkers; Microbiome; Pneumonia; Sepsis

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; HUMAN; INCIDENCE; INFECTION RISK; LUNG; LUNG INFECTION; MICROBIOME; NATIONAL HEALTH ORGANIZATION; NONHUMAN; PATHOGEN CLEARANCE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEPSIS; TISSUE INJURY; VIRAL RESPIRATORY TRACT INFECTION;

BIOMARKERS; MICROBIOME; PNEUMONIA; SEPSIS;

BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HIV INFECTIONS; HUMANS; MICROBIOTA; PNEUMONIA; RESPIRATORY SYSTEM; SEPSIS; TROPHERYMA; UNITED STATES;

EID: 84903829354     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201403-0577UP     Document Type: Article

References (60)

1. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 2013;187: 1382-1387.
2. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, et al.; Lung HIV Microbiome Project. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 2013; 187: 1067-1075.
3. Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES, Sodergren E, Mitreva M, Abubucker S, Martin J, Yao G, et al.; Lung HIV Microbiome Project. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 2013;187: 1110-1117.
4. Stein A, Doutchi M, Fenollar F, Raoult D. Tropheryma whipplei pneumonia in a patient with HIV-2 infection. Am J Respir Crit Care Med 2013;188: 1036-1037.
5. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, Good JT Jr, Gelfand EW, Martin RJ, Leung DY. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013;188: 1193-1201.
6. Huang YJ, Boushey HA. The bronchial microbiome and asthma phenotypes. Am J Respir Crit Care Med 2013;188: 1178-1180.
7. Ege M, von Mutius E. Microbial airway colonization: a cause of asthma and pneumoniäAm J Respir Crit Care Med 2013;188: 1188-1189.
8. Vissing NH, Chawes BLK, Bisgaard H. Increased risk of pneumonia and bronchiolitis after bacterial colonization of the airways as neonates. Am J Respir Crit Care Med 2013;188: 1246-1252.
9. von Linstow M-L, Schønning K, Hoegh AM, Sevelsted A, Vissing NH, Bisgaard H. Neonatal airway colonization is associated with troublesome lung symptoms in infants. Am J Respir Crit Care Med 2013;188: 1041-1042.
10. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SAG, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188: 1224-1231.
11. Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013; 187: 1118-1126.
12. Dickson RP, Huang YJ, Martinez FJ, Huffnagle GB. The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches. Am J Respir Crit Care Med 2013;188: 1185-1186.
13. Miravitlles M, Anzueto A. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;188: 1052-1057.
14. Harris JK, Zemanick ET. Microbes in bronchiectasis: the forest or the trees? Am J Respir Crit Care Med 2013;187: 1044-1045.
15. Willner DL, Hugenholtz P, Yerkovich ST, Tan ME, Daly JN, Lachner N, Hopkins PM, Chambers DC. Reestablishment of recipientassociated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2013; 187: 640-647.
16. Gregson AL, Wang X, Weigt SS, Palchevskiy V, Lynch JP III, Ross DJ, Kubak BM, Saggar R, Fishbein MC, Ardehali A, et al. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med 2013;187: 518-526.
17. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, et al. Risk factors for drug-resistant pathogens in community-Acquired and healthcare-Associated pneumonia. Am J Respir Crit Care Med 2013;188: 985-995.
18. Wunderink RG. Community-Acquired pneumonia versus healthcareassociated pneumonia. The returning pendulum. Am J Respir Crit Care Med 2013;188: 896-898.
19. Planquette B, Timsit J-F, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, et al.; OUTCOMEREA Study Group. Pseudomonas aeruginosa ventilator-Associated pneumonia. predictive factors of treatment failure. Am J Respir Crit Care Med 2013;188: 69-76.
20. Shah FA, Pike F, Alvarez K, Angus D, Newman AB, Lopez O, Tate J, Kapur V, Wilsdon A, Krishnan JA, et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med 2013;188: 586-592.
21. Sellares J, Ló pez-Giraldo A, Lucena C, Cilloniz C, Amaro R, Polverino E, Ferrer M, Mené ndez R, Mensa J, Torres A. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-Acquired pneumonia. Am J Respir Crit Care Med 2013; 187: 1241-1248.
22. Mehta AJ, Yeligar SM, Elon L, Brown LA, Guidot DM. Alcoholism causes alveolar macrophage zinc deficiency and immune dysfunction. Am J Respir Crit Care Med 2013;188: 716-723.
23. Janssen WJ. Alveolar macrophage dysfunction and chronic alcohol use. Time to think about zinc. Am J Respir Crit Care Med 2013;188: 635-636.
24. Tian L, Qiu H, Pun VC, Lin H, Ge E, Chan JC, Louie PK, Ho KF, Yu IT. Ambient carbon monoxide associated with reduced risk of hospital admissions for respiratory tract infections. Am J Respir Crit Care Med 2013;188: 1240-1245.
25. Goldberg HJ, Holguin F. Carbon monoxide in small doses -A good thing? Am J Respir Crit Care Med 2013;188: 1187-1188. (PubMed)
26. Ferreira DM, Neill DR, Bangert M, Gritzfeld JF, Green N, Wright AKA, Pennington SH, Bricio-Moreno L, Moreno AT, Miyaji EN, et al. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med 2013;187: 855-864.
27. Gonzalez BE, Jacobs MR. The potential of human nasal colonization with Streptococcus pneumoniae as a universal pneumococcal vaccine. Am J Respir Crit Care Med 2013;187: 794-795.
28. Ortiz JR, Neuzil KM, Rue TC, Zhou H, Shay DK, Cheng P-Y, Cooke CR, Goss CH. Population-based incidence estimates of influenzaassociated respiratory failure hospitalizations, 2003 to 2009. Am J Respir Crit Care Med 2013;188: 710-715.
29. Wang Y, Zhang Y, Wang H, Zhou Z, Zhou Z, Gu Q, Wu C, Zhu B. Sharing insights and H7N9 patient clinical data. Am J Respir Crit Care Med 2013;188: 115-117.
30. Jie Z, Xie J, He Z, Song Y, Hu Y, Li F, Shen Y, Shi J, He Y, Huang Q, et al. Family outbreak of severe pneumonia induced by H7N9 infection. Am J Respir Crit Care Med 2013;188: 114-115.
31. Lamb RA. Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson? Am J Respir Crit Care Med 2013;188: 1-2.
32. MacIntyre CR, Wang Q, Seale H, Yang P, Shi W, Gao Z, Rahman B, Zhang Y, Wang X, Newall AT, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 2013;187: 960-966.
33. Bessesen MT, Savor-Price C, Simberkoff M, Reich NG, Pavia AT, Radonovich LJ. N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet? Am J Respir Crit Care Med 2013;187: 904-905.
34. Stein RT. Severe respiratory syncytial virus bronchiolitis in underserved populations and the association with unhealthy diets during pregnancy. Am J Respir Crit Care Med 2013;187: 908-909.
35. Ferolla FM, Hijano DR, Acosta PL, Rodŕiguez A, Dueñas K, Sancilio A, Barboza E, Caŕia A, Gago GF, Almeida RE, et al. Macronutrients during pregnancy and life-Threatening respiratory syncytial virus infections in children. Am J Respir Crit Care Med 2013;187: 983-990.
36. Tripp RA. Modeling respiratory syncytial virus cytopathogenesis in the human airway. Am J Respir Crit Care Med 2013;188: 766-767.
37. Guo-Parke H, Canning P, Douglas I, Villenave R, Heaney LG, Coyle PV, Lyons JD, Shields MD, Power UF. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 2013;188: 842-851. (PubMed).
38. Cox DW, Bizzintino J, Ferrari G, Khoo SK, Zhang G, Whelan S, Lee WM, Bochkov YA, Geelhoed GC, Goldblatt J, et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med 2013;188: 1358-1364.
39. Camargo CA Jr. Human rhinovirus, wheezing illness, and the primary prevention of childhood asthma. Am J Respir Crit Care Med 2013; 188: 1281-1282.
40. Hocke AC, Becher A, Knepper J, Peter A, Holland G, Tönnies M, Bauer TT, Schneider P, Neudecker J, Muth D, et al. Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med 2013;188: 882-886. (PubMed).
41. Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, et al.; REVA Research Network. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013;187: 276-285.
42. Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 2013;187: 509-517.
43. Lerolle N, Carlotti A, Melican K, Aubey F, Pierrot M, Diehl J-L, Caille V, H́ekimian G, Gandrille S, Mandet C, et al. Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans. Am J Respir Crit Care Med 2013;188: 684-692.
44. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, et al. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 2013; 187: 65-77.
45. Foell D, Wittkowski H, Kessel C, Lüken A, Weinhage T, Varga G, Vogl T, Wirth T, Viemann D, Björk P, et al. Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4. Am J Respir Crit Care Med 2013;187: 1324-1334.
46. Chen Q, Zhang K, Jin Y, Zhu T, Cheng B, Shu Q, Fang X. Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. Am J Respir Crit Care Med 2013;188: 201-212.
47. Kager LM, Weehuizen TA, Wiersinga WJ, Roelofs JJTH, Meijers JCM, Dondorp AM, van 't Veer C, van der Poll T. Endogenous a2-Antiplasmin is protective during severe gram-negative sepsis (melioidosis). Am J Respir Crit Care Med 2013;188: 967-975.
48. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311: 1308-1316. (PubMed).
49. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41: 580-637. (PubMed).
50. Miller RR III, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, Allen TL, Clemmer TP; Intermountain Healthcare Intensive Medicine Clinical Program. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med 2013;188: 77-82.
51. Annane D, Timsit J-F, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, et al.; APROCCHSS Trial Investigators. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2013;187: 1091-1097.
52. Kruger P, Bailey M, Bellomo R, Cooper DJ, Harward M, Higgins A, Howe B, Jones D, Joyce C, Kostner K, et al.; ANZ-STATInS Investigators-ANZICS Clinical Trials Group. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis. Am J Respir Crit Care Med 2013;187: 743-750.
53. Papazian L, Roch A, Charles PE, Penot-Ragon C, Perrin G, Roulier P, Goutorbe P, Lefrant JY, Wiramus S, Jung B, et al.; STATIN-VAP Study Group. Effect of statin therapy on mortality in patients with ventilator-Associated pneumonia: a randomized clinical trial. JAMA 2013;310: 1692-1700. (PubMed).
54. Walkey AJ, Ambrus D, Benjamin EJ. The role of arrhythmias in defining cardiac dysfunction during sepsis. Am J Respir Crit Care Med 2013; 188: 751. (PubMed).
55. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310: 1683-1691. (PubMed).
56. Mickiewicz B, Vogel HJ, Wong HR, Winston BW. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013;187: 967-976.
57. Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, et al.; Fungal Infection Network of Switzerland (FUNGINOS). b-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 2013;188: 1100-1109.
58. Russell JA, Walley KR, Singer J, Gordon AC, Hé bert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al.; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358: 877-887. (PubMed).
59. Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S, Singer J, Patterson AJ, Walley KR. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med 2013;188: 356-364.
60. Timsit J-F, Bouadma L, Mimoz O, Parienti J-J, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, et al. Jugular versus femoral short-Term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials. Am J Respir Crit Care Med 2013;188: 1232-1239.